drugset / Trial / NCT00970762

Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED)

NCT00970762

Phase 3 Completed 90 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

This study was conducted to determine and compare the safety and effectiveness of two neuromuscular blockers (rocuronium and vecuronium) at various doses in adults who are undergoing general elective surgery with sevoflurane anesthesia. Study participants received an intubating dose of a neuromuscular blocker (to enable insertion of a tube through the nose or mouth into the trachea to provide artificial ventilation). The intubating dose was followed by repeated bolus maintenance doses as needed, to maintain muscle relaxation. The time it takes to reach maximal effect of the neuromuscular blocker (onset time) after the intubating dose was measured and compared as the primary outcome.

Timeline

Start
2003-02
Primary completion
2004-02
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified 0.1 mg/kg
Subject Rocuronium Other / unclassified 0.15 mg/kg
Subject Rocuronium Other / unclassified 0.2 mg/kg
Comparator Vecuronium Small molecule 0.025 mg/kg

Indications

No indication recorded.